From: Hauora Māori – Māori health: a right to equal outcomes in primary care
Polypharmacy in people age ≥ 65 R2 = 0.4466 N = 56,280 | HbA1c in people with diabetes R2 = 0.1755 N = 21,586 | Immunisations at age 6 months R2 = 0.0811 N = 4,775 | Child ASH R2 not applicable N = 118,889 | Adult ASH R2 not applicable N = 73,950 | ED attendances R2 not applicable N = 366,486 | |
---|---|---|---|---|---|---|
Overall mean | 33.4% | 80.9% | 63.6% | 44 per 1000 enrolled children | 77 per 1000 enrolled adults | 365 per 1000 enrolled patients |
Estimate p value | Estimate p value | Estimate p value | Estimate p value | Estimate p value | Estimate p value | |
Intercept | -2.203534 | 1.105886 | 0.584101 | -4.00084 | -4.13696 | -2.109394 |
0 *** | 0 *** | 3e-06 *** | 0 *** | 0 *** | 0 *** | |
Practice models | ||||||
Corporate a | -0.165781 | -0.142365 | -0.13325 | -0.09902 | 0.191857 | -0.020883 |
0.009601 ** | 0.195163 | 0.36815 | 0.462772 | 0.013186 * | 0.577196 | |
PHO/DHB a | -0.146741 | -0.227092 | -0.31994 | -0.02732 | 0.411895 | 0.150022 |
0.220088 | 0.281985 | 0.254857 | 0.913146 | 0.005077 ** | 0.040814 * | |
Trust/NGO a | 0.011866 | 0.097556 | 0.205518 | 0.344206 | 0.316441 | 0.23071 |
0.889102 | 0.564796 | 0.349084 | 0.021422 * | 0.004577 ** | 9e-05 *** | |
HCH Practice b | -0.080916 | -0.004833 | 0.277053 | 0.053086 | -0.05016 | -0.06501 |
0.035649 * | 0.954487 | 0.003089 ** | 0.306358 | 0.375549 | 0.040928 * | |
Māori Practice b | -0.182819 | -0.241891 | -0.56065 | -0.10639 | -0.13757 | -0.048903 |
0.014506 * | 0.143095 | 0.003662 ** | 0.302633 | 0.18591 | 0.425907 | |
Pacific Practice b | -0.190856 | 0.080802 | -1.19511 | -0.40935 | -0.75323 | -0.253206 |
0.267265 | 0.786684 | 0.009291 ** | 0.076001 | 0.003492 ** | 0.01661 * | |
Patient factors | ||||||
Age 00–04 | -3.595615 | 0.22549 | 0.508938 | |||
1.2e-05 *** | 0 *** | 0 *** | ||||
Age 05–09 | -4.455915 | reference | -0.041319 | |||
0 *** | 0.045345 * | |||||
Age 10–14 | -2.319399 | -0.96348 | 0.031559 | |||
0 *** | 0 *** | 0.137948 | ||||
Age 15–19 | -1.432507 | 0.462977 | ||||
0 *** | 0 *** | |||||
Age 20–24 | -1.139149 | 0.582737 | ||||
0 *** | 0 *** | |||||
Age 25–29 | -0.875194 | 0.422451 | ||||
0 *** | 0 *** | |||||
Age 30–34 | -0.59253 | 0.282423 | ||||
0 *** | 0 *** | |||||
Age 35–39 | -0.408235 | 0.167026 | ||||
3.2e-05 *** | 0 *** | |||||
Age 40–44 | -0.128773 | 0.079423 | ||||
0.156121 | 0.000559 *** | |||||
Age 45–49 | Reference | -0.1387 | Reference | |||
0.007081 ** | ||||||
Age 50–54 | 0.14116 | Reference | -0.042569 | |||
0.075067 | 0.064319 | |||||
Age 55–59 | -1.181874 | 0.354513 | 0.01749 | -0.14237 | ||
0 *** | 5e-06 *** | 0.720436 | 0 *** | |||
Age 60–64 | -0.819014 | 0.528367 | -0.00722 | -0.160126 | ||
0 *** | 0 *** | 0.889479 | 0 *** | |||
Age 65–69 | -0.480979 | 0.462988 | -0.212001 | |||
0 *** | 0 *** | 0 *** | ||||
Age 70–74 | -0.212458 | 0.545326 | -0.174538 | |||
3.3e-05 *** | 0 *** | 0 *** | ||||
Age 75–59 | Reference | 0.446933 | -0.074983 | |||
2.2e-05 *** | 0.033079 * | |||||
Age 80–84 | 0.022677 | 0.197183 | -0.020303 | |||
0.743895 | 0.11547 | 0.645975 | ||||
Age 85 + | 0.232713 | -0.104139 | 0.207933 | |||
0.005858 ** | 0.513466 | 6.7e-05 *** | ||||
Male c | 0.011643 | 0.140714 | ||||
0.763229 | 0.000169 *** | |||||
Quintile 5 c | -0.066351 | |||||
0.104868 | ||||||
IMD d | 0.045574 | -0.15201 | 0.101755 | 0.12766 | 0.076927 | |
0.000344 *** | 2.3e-05 *** | 0 *** | 0 *** | 0 *** | ||
Diabetes c | 1.61725 | 0.118262 | ||||
0 *** | 0.006907 ** | |||||
Gout c | 1.268493 | 0.27879 | 0.089678 | |||
0 *** | 0 *** | 0.111175 | ||||
HbA1c test c | 0.375364 | |||||
0 *** | ||||||
SSRI c | 1.059998 | 0.260437 | ||||
0 *** | 0 *** | |||||
Tramadol c | 0.459292 | 0.892234 | ||||
0 *** | 0 *** | |||||
Antibiotics c | 0.2975 | 0.291107 | 0.829183 | 0.970391 | 0.616753 | |
0 *** | 0 *** | 0 *** | 0 *** | 0 *** | ||
M3 d | 0.660593 | -0.264025 | 1.896788 | 0.939156 | 0.681459 | |
0 *** | 0 *** | 0 *** | 0 *** | 0 *** | ||
Continuity of practice c | -0.14405 | -0.26749 | -0.305727 | |||
2.4e-05 *** | 0 *** | 0 *** | ||||
First Specialist Assessment d | 0.076018 | 0.060579 | 0.353798 | 0.2789 | 0.295668 | |
0.000108 *** | 0.056068 | 0 *** | 0 *** | 0 *** | ||
FSA Did Not Attend d | -0.18188 | 0.092618 | 0.507525 | 0.369589 | ||
0.170847 | 0.23251 | 0 *** | 0 *** | |||
Practice factors | ||||||
Urban c | 0.011164 | -0.054702 | 0.065662 | -0.04651 | -0.07605 | |
0.753151 | 0.503673 | 0.552787 | 0.372884 | 0.23598 | ||
VLCAc | -0.098921 | -0.14957 | ||||
0.177128 | 0.081755 | |||||
Continuity of GP d | -0.11821 | |||||
0.135424 | ||||||
Distance to nearest ED d | -0.02875 | -0.05262 | -0.102692 | |||
0.483513 | 0.037277 * | 0 *** | ||||
Primary care clinical input | ||||||
NP + GP consults d | 0.15582 | 0.09311 | 0.022251 | 0.071637 | 0.051258 | 0.068116 |
0 *** | 0 *** | 0.059271 | 0 *** | 0 *** | 0 *** | |
RN hours d | 0.14258 | 0.118932 | ||||
0.000643 *** | 0.009092 ** | |||||
GP hours d | 0.338837 | 0.031598 | ||||
-0.00266 | 0.091842 | |||||
Interactions | ||||||
NP + GP consults X Corporate a | 0.04552 | 0.010572 | -0.03608 | 0.027746 | -0.00844 | 0.009074 |
0.000226 *** | 0.592731 | 0.160883 | 0.018895 * | 0.36928 | 0.001684 ** | |
NP + GP consults X PHO/DHB a | 0.056796 | 0.050163 | 0.022056 | 0.015166 | 0.019328 | 0.016385 |
0.022128 * | 0.247839 | 0.687908 | 0.596488 | 0.360744 | 0.010759 * | |
NP + GP consults X Trust/NGO a | 0.027916 | -0.00713 | -0.02301 | 0.018628 | -0.00218 | 0.001728 |
0.012868 * | 0.689318 | 0.376409 | 0.104953 | 0.797324 | 0.535464 | |
RN hours X Corporate a | -0.105067 | -0.16496 | ||||
0.262851 | 0.119132 | |||||
RN hours X PHO/DHB a | 0.006266 | -0.00852 | ||||
0.965215 | 0.954599 | |||||
RN hours X Trust/NGO a | -0.067274 | -0.23994 | ||||
0.404552 | 0.017736 * | |||||
GP hours X Corporate a | 0.051979 | -0.12916 | ||||
0.585034 | 0.002464 ** | |||||
GP hours X PHO/DHB a | -0.04751 | -0.03497 | ||||
0.807839 | 0.705262 | |||||
GP hours X Trust/NGO a | -0.0895 | -0.10583 | ||||
0.372925 | 0.010701 * | |||||
Continuity of GP X Corporate a | -0.03881 | |||||
0.811535 | ||||||
Continuity of GP X PHO/DHB a | 0.094332 | |||||
0.768363 | ||||||
Continuity of GP X Trust/NGO a | -0.12182 | |||||
0.432376 |